financetom
Business
financetom
/
Business
/
What's Going On With D-Wave Quantum Stock Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With D-Wave Quantum Stock Today?
Jan 10, 2025 6:54 AM

D-Wave Quantum Inc. ( QBTS ) on Friday said it expects significant booking growth for fiscal year 2024.

The company reported that its bookings will exceed $23 million, marking a 120% increase over fiscal year 2023.

The company’s CEO Alan Baratz has criticized Nvidia Corp. CEO Jensen Huang for his comments regarding the timeline for achieving practical quantum computing, saying he is “dead wrong.”

Huang’s remarks during Nvidia’s analyst day, suggesting a 15 to 30-year wait for “very useful quantum computers,” have sparked a heated debate in the tech community.

A key driver of D-Wave’s growth is the first-ever customer purchase of the D-Wave Advantage system, a quantum computer with over 5,000 qubits.

This sale signals a major expansion of D-Wave’s revenue model, as it begins offering on-premise quantum systems in addition to its cloud services.

Also Read: Quantum Stocks Regetti Computing, IonQ, D-Wave Poised To Open Higher After Nvidia CEO Comments Drove Huge Losses

The Advantage system provides customers full access to its capabilities, allowing them to modify system parameters and integrate it into their own infrastructure.

D-Wave’s growing customer base, including research centers and businesses, highlights the increasing demand for quantum computing solutions, particularly for addressing challenges in AI power consumption and national security.

Additionally, D-Wave disclosed that its fiscal fourth-quarter 2024 bookings will reach at least $18 million, a staggering 500% increase over the same period last year.

The company also ended the fiscal year with a strong cash position of approximately $178 million.

Price Action: QBTS shares are trading higher by 0.66% to $6.14 premarket at last check Friday.

Read Next:

US Stocks To Open On A Tentative Note As Traders Remain Cautious Ahead Of Friday’s Crucial Jobs Data

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US SEC probes MassMutual over accounting practices, WSJ reports
US SEC probes MassMutual over accounting practices, WSJ reports
Oct 8, 2025
(Reuters) -U.S. regulators are investigating Massachusetts Mutual Life Insurance over its accounting practices in investment operations, the Wall Street Journal reported on Wednesday. The Securities and Exchange Commission has issued subpoenas seeking information about MassMutual's bookkeeping around income on billions of dollars of loans it holds in its general investment account, the report said, citing people familiar with the matter....
Bicara Therapeutics Insider Sold Shares Worth $553,198, According to a Recent SEC Filing
Bicara Therapeutics Insider Sold Shares Worth $553,198, According to a Recent SEC Filing
Oct 8, 2025
05:38 PM EDT, 10/08/2025 (MT Newswires) -- Ivan Hyep, Chief Financial Officer, on October 06, 2025, sold 30,385 shares in Bicara Therapeutics ( BCAX ) for $553,198. Following the Form 4 filing with the SEC, Hyep has control over a total of 145,355 common shares of the company, with 145,355 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/2023658/000203466825000004/xslF345X05/wk-form4_1759959228.xml ...
EU Parliament plans to cut back sustainability law further
EU Parliament plans to cut back sustainability law further
Oct 8, 2025
* Lawmaker groups agree to further weaken corporate sustainability law * Deal would apply law to firms with at least 5,000 employees, 1.5 billion euros turnover * Socialists compromise to avoid 'worse' deal with far-right lawmakers By Kate Abnett BRUSSELS, Oct 8 (Reuters) - Lawmaker groups holding a majority in the European Parliament agreed a deal late on Wednesday to...
Bicara Therapeutics Insider Sold Shares Worth $911,842, According to a Recent SEC Filing
Bicara Therapeutics Insider Sold Shares Worth $911,842, According to a Recent SEC Filing
Oct 8, 2025
05:39 PM EDT, 10/08/2025 (MT Newswires) -- Ryan Cohlhepp, Director, President and COO, on October 06, 2025, sold 50,500 shares in Bicara Therapeutics ( BCAX ) for $911,842. Following the Form 4 filing with the SEC, Cohlhepp has control over a total of 202,641 common shares of the company, with 202,641 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/2023658/000203466525000004/xslF345X05/wk-form4_1759959205.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved